20/20 Biolabs (AIDX) okays 2026 equity plan but pushes charter vote
Rhea-AI Filing Summary
20/20 Biolabs, Inc. (AIDX) reported the results of its August 18, 2026 annual stockholders meeting held via webcast. Stockholders of record on June 22, 2026, holding 12,251,198 common shares, were entitled to vote, and 4,256,837 shares were represented, constituting a quorum.
Six directors were elected, each receiving roughly 2.65–2.73 million votes for and about 156–176 thousand votes withheld, with 1,433,721 broker non-votes on each director. Stockholders ratified dbbmckennon as independent registered public accounting firm for 2026 with 4,105,584 votes for, 132,421 against, and 18,832 abstentions. They also approved the 2026 Equity Incentive Plan with 2,183,335 votes for, 573,931 against, 65,850 abstentions, and 1,433,721 broker non-votes, and approved the ability to adjourn the meeting if needed, by 3,037,106 votes for, 1,132,166 against, and 87,565 abstentions. A charter amendment proposal did not receive sufficient votes and the meeting was adjourned on that item to September 16, 2026.
Positive
- None.
Negative
- None.
Insights
Analyzing...
8-K Event Classification
Item 5.07 — Submission of Matters to a Vote of Security Holders
1 item
Item 5.07
Submission of Matters to a Vote of Security Holders
Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Key Figures
Shares outstanding entitled to vote: 12,251,198 shares
Shares represented at meeting: 4,256,837 shares
Broker non-votes on director elections: 1,433,721
+3 more
6 metrics
Shares outstanding entitled to vote
12,251,198 shares
Common stock outstanding and entitled to vote as of June 22, 2026
Shares represented at meeting
4,256,837 shares
Shares present in person or by proxy at August 18, 2026 annual meeting
Broker non-votes on director elections
1,433,721
Broker non-votes recorded on each of the six director election proposals
Auditor ratification votes for
4,105,584
Votes in favor of ratifying dbbmckennon for fiscal year ending December 31, 2026
Equity Plan approval votes for
2,183,335
Votes in favor of the 2026 Equity Incentive Plan
Adjournment proposal votes for
3,037,106
Votes in favor of allowing adjournment to solicit additional proxies
Key Terms
broker non-votes, quorum, independent registered public accounting firm, Equity Incentive Plan, +1 more
5 terms
broker non-votes financial
"The votes regarding this proposal were as follows ... Broker Non-Votes"
Broker non-votes occur when a brokerage firm is unable to vote on a shareholder’s behalf during a company election or decision because the shareholder has not given specific voting instructions, and the broker is not allowed or chooses not to vote on certain matters. They are important because they can affect the outcome of votes, especially when the results are close, by effectively reducing the total number of votes cast.
quorum regulatory
"4,256,837 shares of common stock were represented...constituting a quorum"
A quorum is the minimum number of members needed to officially hold a meeting or make decisions. It ensures that decisions are made with enough participation to represent the group’s interests, much like a majority must be present for a vote to be valid. For investors, understanding quorum is important because it affects when and how important company or organization decisions can be legally made.
independent registered public accounting firm financial
"ratified the appointment of dbbmckennon as the Company’s independent registered public accounting firm"
An independent registered public accounting firm is an outside accounting company officially registered with the government regulator to examine and report on a public company's financial records and controls. Investors treat its reports like an impartial inspector’s certificate — they add credibility to financial statements, help spot errors or misleading claims, and reduce the risk that shareholders are relying on unchecked or biased numbers.
Equity Incentive Plan financial
"The Company’s stockholders approved the Company’s 2026 Equity Incentive Plan"
An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.
adjournment of the Annual Meeting regulatory
"approved the adjournment of the Annual Meeting to a later date if necessary"
FAQ
What did 20/20 Biolabs, Inc. (AIDX) announce regarding its 2026 annual meeting?
20/20 Biolabs, Inc. announced final voting results from its August 18, 2026 annual meeting. Six directors were elected, the auditor was ratified, a 2026 Equity Incentive Plan was approved, and stockholders authorized potential adjournment to solicit additional proxies.
Were all director nominees elected at 20/20 Biolabs’ 2026 annual meeting?
Yes. All six nominees to the 20/20 Biolabs board were elected. Each director received about 2.65–2.73 million votes for, between roughly 156,000 and 176,000 votes withheld, and there were 1,433,721 broker non-votes for each director election.
Did AIDX stockholders ratify the company’s independent auditor for 2026?
Yes. Stockholders ratified dbbmckennon as independent registered public accounting firm for the year ending December 31, 2026, with 4,105,584 votes for, 132,421 against, and 18,832 abstentions, indicating strong support for the appointment.
Was 20/20 Biolabs’ 2026 Equity Incentive Plan approved by AIDX stockholders?
Yes. The 2026 Equity Incentive Plan was approved with 2,183,335 votes for, 573,931 against, 65,850 abstentions, and 1,433,721 broker non-votes. This authorization allows grants of equity-based awards under the new plan structure going forward.
What happened to the charter amendment proposal at AIDX’s 2026 annual meeting?
The charter amendment proposal did not receive sufficient votes at the August 18, 2026 meeting. In line with a separate adjournment proposal, the company adjourned voting on this item until September 16, 2026 to solicit additional proxies.
What was decided about adjourning 20/20 Biolabs’ 2026 annual meeting if needed?
Stockholders approved the ability to adjourn the annual meeting to solicit more proxies if needed. The adjournment proposal received 3,037,106 votes for, 1,132,166 against, and 87,565 abstentions, enabling the later adjournment on the charter amendment.
AI-generated analysis. How Rhea-AI works. Not financial advice.
